MGRX
Mangoceuticals, Inc. Common Stock
NASDAQ: MGRX · HEALTHCARE · HEALTH INFORMATION SERVICES
$0.34
+2.56% today
Updated 2026-04-30
Market cap
$6.79M
P/E ratio
—
P/S ratio
14.88x
EPS (TTM)
$-2.17
Dividend yield
—
52W range
$0 – $3
Volume
15.5M
Mangoceuticals, Inc. Common Stock (MGRX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-1,576.00%
ROE
-141.70%
ROA
-69.90%
Debt/equity
0.01x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2021 | — | $-17701.00 | — | — | — |
| 2022 | $8939.00 | $-2.00M | 54.26% | -22,279.70% | -22,352.11% |
| 2023 | $731493.00 | $-9.21M | 58.99% | -1,260.28% | -1,259.40% |
| 2024 | $615873.00 | $-8.71M | 61.70% | -1,294.42% | -1,413.60% |
| 2025 | $456021.00 | $-20.64M | 54.91% | -4,200.46% | -4,526.86% |